BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 8916036)

  • 21. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo.
    Sun W; Lee DK; Lee CC; Kim K
    Mol Reprod Dev; 1996 Apr; 43(4):414-20. PubMed ID: 9052931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
    Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
    Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytometry of cyclin proteins.
    Darzynkiewicz Z; Gong J; Juan G; Ardelt B; Traganos F
    Cytometry; 1996 Sep; 25(1):1-13. PubMed ID: 8875049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
    Li Y; Jenkins CW; Nichols MA; Xiong Y
    Oncogene; 1994 Aug; 9(8):2261-8. PubMed ID: 7913544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the contribution of changes in mRNA stability to the changes in steady-state levels of cyclin mRNA in the mammalian cell cycle.
    Penelova A; Richman L; Neupert B; Simanis V; Kühn LC
    FEBS J; 2005 Oct; 272(20):5217-29. PubMed ID: 16218953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
    Serrano M; Hannon GJ; Beach D
    Nature; 1993 Dec; 366(6456):704-7. PubMed ID: 8259215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
    Qi Y; Tu Y; Yang D; Chen Q; Xiao J; Chen Y; Fu J; Xiao X; Zhou Z
    J Cell Physiol; 2007 Jan; 210(1):63-71. PubMed ID: 17013808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation.
    Poon RY; Toyoshima H; Hunter T
    Mol Biol Cell; 1995 Sep; 6(9):1197-213. PubMed ID: 8534916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cyclin D, CDK4 and p16 expression in colorectal cancer].
    Ikeda K; Monden T; Tsujie M; Izawa H; Yamamoto H; Ohnishi T; Ohue M; Sekimoto M; Tomita N; Monden M
    Nihon Rinsho; 1996 Apr; 54(4):1054-9. PubMed ID: 8920673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes.
    Tanguay DA; Chiles TC
    J Immunol; 1996 Jan; 156(2):539-48. PubMed ID: 8543804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meiotic cell cycle in Xenopus oocytes is independent of cdk2 kinase.
    Furuno N; Ogawa Y; Iwashita J; Nakajo N; Sagata N
    EMBO J; 1997 Jul; 16(13):3860-5. PubMed ID: 9233796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stabilization of cyclin E and cdk2 mRNAs at G1/S transition in Rat-1A cells emerging from the G0 state.
    Oda S; Nishida J; Nakabeppu Y; Sekiguchi M
    Oncogene; 1995 Apr; 10(7):1343-51. PubMed ID: 7731685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern of expression of cyclin D1/CDK4 complex in human placenta during gestation.
    De Falco M; Fedele V; Cobellis L; Mastrogiacomo A; Giraldi D; Leone S; De Luca L; Laforgia V; De Luca A
    Cell Tissue Res; 2004 Aug; 317(2):187-94. PubMed ID: 15221443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of G1 progression by D-type cyclins: key event for cell proliferation.
    Kato JY
    Leukemia; 1997 Apr; 11 Suppl 3():347-51. PubMed ID: 9209386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal expressions of cyclins and cyclin dependent kinases during renal development and compensatory growth.
    Park SK; Kang SK; Lee DY; Kang MJ; Kim SH; Koh GY
    Kidney Int; 1997 Mar; 51(3):762-9. PubMed ID: 9067908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell cycle and cancer: genetic analysis of the role of cyclin-dependent kinases.
    Barbacid M; Ortega S; Sotillo R; Odajima J; Martín A; Santamaría D; Dubus P; Malumbres M
    Cold Spring Harb Symp Quant Biol; 2005; 70():233-40. PubMed ID: 16869759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cdk2 activity is dispensable for the onset of DNA replication during the first mitotic cycles of the sea urchin early embryo.
    Moreau JL; Marques F; Barakat A; Schatt P; Lozano JC; Peaucellier G; Picard A; Genevière AM
    Dev Biol; 1998 Aug; 200(2):182-97. PubMed ID: 9705226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.